UNIGE document Scientific Article
previous document  unige:152352  next document
add to browser collection
Title

Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells

Authors
Seguin, Laetitia
Yebra, Mayra
show hidden authors show all authors [1 - 20]
Published in Communications biology. 2021, vol. 4, no. 1, 718
Abstract Recently, we involved the carbohydrate-binding protein Galectin-3 (Gal-3) as a druggable target for KRAS-mutant-addicted lung and pancreatic cancers. Here, using glioblastoma patient-derived stem cells (GSCs), we identify and characterize a subset of Gal-3high glioblastoma (GBM) tumors mainly within the mesenchymal subtype that are addicted to Gal-3-mediated macropinocytosis. Using both genetic and pharmacologic inhibition of Gal-3, we showed a significant decrease of GSC macropinocytosis activity, cell survival and invasion, in vitro and in vivo. Mechanistically, we demonstrate that Gal-3 binds to RAB10, a member of the RAS superfamily of small GTPases, and β1 integrin, which are both required for macropinocytosis activity and cell survival. Finally, by defining a Gal-3/macropinocytosis molecular signature, we could predict sensitivity to this dependency pathway and provide proof-of-principle for innovative therapeutic strategies to exploit this Achilles' heel for a significant and unique subset of GBM patients.
Identifiers
PMID: 34112916
Full text
Structures
Research groups Immunothérapie des cancers (42)
Radicaux libres et cellules souches embryonnaires (60)
Voies de signalisation oncogéniques (998)
Citation
(ISO format)
SEGUIN, Laetitia et al. Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells. In: Communications Biology, 2021, vol. 4, n° 1, p. 718. doi: 10.1038/s42003-021-02258-z https://archive-ouverte.unige.ch/unige:152352

194 hits

88 downloads

Update

Deposited on : 2021-06-14

Export document
Format :
Citation style :